ECHO THERAPEUTICS Stock Today

ECHO THERAPEUTICS INC is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day ECHO THERAPEUTICS was actively traded.
Valuation Profit Patterns
Check how we calculate scores

ECHO THERAPEUTICS Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. ECHO THERAPEUTICS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ECHO THERAPEUTICS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ECHO THERAPEUTICS is not currently marked as verified by its exchange. Report It!
ECHO THERAPEUTICS Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
ECHO THERAPEUTICS INC SEC Filings
ECHO THERAPEUTICS SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameECHO THERAPEUTICS INC
Related EntityPHON (Echo Therapeutics)
CEO and President and DirectorScott Hollander  (View All)
Thematic Classifications
Active investing themes ECHO THERAPEUTICS currently participates. (view all). An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of ECHO THERAPEUTICS INC based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of ECHO THERAPEUTICS INC financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares10.9 M12.9 M
Fairly Down
Increasing
Slightly volatile
Weighted Average Shares Diluted10.9 M12.9 M
Fairly Down
Increasing
Slightly volatile
Total Assets743.6 K724.6 K
Fairly Up
Decreasing
Slightly volatile
Total Liabilities3.4 MM
Moderately Up
Decreasing
Stable
Current Assets277.8 K270.7 K
Fairly Up
Decreasing
Slightly volatile
Current Liabilities3.3 M2.9 M
Moderately Up
Decreasing
Stable
Total Debt409.5 K379.5 K
Significantly Up
Increasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.00280.0027
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ECHO THERAPEUTICS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
Financial Strength
ECHO THERAPEUTICS's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ECHO THERAPEUTICS's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ECHO THERAPEUTICS's financial leverage. It provides some insight into what part of ECHO THERAPEUTICS's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on ECHO THERAPEUTICS's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how ECHO THERAPEUTICS deploys its capital and how much of that capital is borrowed.
Liquidity
ECHO THERAPEUTICS cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 3.52 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. ECHO THERAPEUTICS INC has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due.

Operating Cash Flow

(4.93 Million)Share
ECHO THERAPEUTICS INC (ECTE) is traded on NASDAQ Exchange in USA. It is located in 99 Wood Avenue South and employs 19 people. ECHO THERAPEUTICS is listed under Medical Equipment category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with current market capitalization of 48.02 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ECHO THERAPEUTICS's market, we take the total number of its shares issued and multiply it by ECHO THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ECHO THERAPEUTICS INC conducts business under Healthcare sector and is part of Medical Devices industry. The entity has 12 M outstanding shares of which 273.27 K shares are currently shorted by private and institutional investors with about 3.4 trading days to cover. ECHO THERAPEUTICS INC currently holds about 172.72 K in cash with (4.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ECHO THERAPEUTICS Probability Of Bankruptcy

ECHO THERAPEUTICS Historical Income Statement

ECHO THERAPEUTICS INC Income Statement is one of the three primary financial statements used for reporting ECHO THERAPEUTICS's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ECHO THERAPEUTICS INC revenue and expense. ECHO THERAPEUTICS Income Statement primarily focuses on the company's revenues and expenses during a particular period.
ECHO THERAPEUTICS Interest Expense is projected to decrease significantly based on the last few years of reporting. The past year's Interest Expense was at 17,644.45. The current year Preferred Dividends Income Statement Impact is expected to grow to about 323.3 K, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to (21.5 M). View More Fundamentals

ECHO THERAPEUTICS Stock Against Markets

Picking the right benchmark for ECHO THERAPEUTICS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ECHO THERAPEUTICS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ECHO THERAPEUTICS is critical whether you are bullish or bearish towards ECHO THERAPEUTICS INC at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ECHO THERAPEUTICS stock to make a market-neutral strategy. Peer analysis of ECHO THERAPEUTICS could also be used in its relative valuation, which is a method of valuing ECHO THERAPEUTICS by comparing valuation metrics with similar companies.

ECHO THERAPEUTICS Corporate Directors

ECHO THERAPEUTICS corporate directors refer to members of an ECHO THERAPEUTICS board of directors. The board of directors generally takes responsibility for the ECHO THERAPEUTICS's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ECHO THERAPEUTICS's board members must vote for the resolution. The ECHO THERAPEUTICS board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Michael Goldberg - DirectorProfile
Elazer Edelman - DirectorProfile
Christine Olimpio - Director of Investor Relations and Corporate CommunicationsProfile
Shepard Goldberg - DirectorProfile
Continue to Investing Opportunities. Note that the ECHO THERAPEUTICS INC information on this page should be used as a complementary analysis to other ECHO THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Tools for ECHO THERAPEUTICS Stock

When running ECHO THERAPEUTICS INC price analysis, check to measure ECHO THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECHO THERAPEUTICS is operating at the current time. Most of ECHO THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ECHO THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ECHO THERAPEUTICS's price. Additionally, you may evaluate how the addition of ECHO THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go